pyrazines has been researched along with azd2858 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jonsson, KB; Larsson, S; Ljunggren, O; Marsell, R; Nilsson, O; Sisask, G; Sundgren-Andersson, A | 1 |
| Gleyzer, N; Scarpulla, RC | 1 |
2 other study(ies) available for pyrazines and azd2858
| Article | Year |
|---|---|
Rats treated with AZD2858, a GSK3 inhibitor, heal fractures rapidly without endochondral bone formation.
Topics: Animals; Biomechanical Phenomena; Bone Density; Bony Callus; Female; Femoral Fractures; Femur; Fracture Healing; Glycogen Synthase Kinase 3; Organ Size; Osteogenesis; Piperazines; Protein Kinase Inhibitors; Pyrazines; Radiography; Rats; Rats, Sprague-Dawley; Sulfonamides | 2013 |
Concerted Action of PGC-1-related Coactivator (PRC) and c-MYC in the Stress Response to Mitochondrial Dysfunction.
Topics: Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Line, Tumor; Glycogen Synthase Kinase 3 beta; Heterocyclic Compounds, 3-Ring; Humans; Mitochondria; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Pyrazines; Signal Transduction; Stress, Physiological; Sulfonamides; Thiazoles; Transcription Factors | 2016 |